134 related articles for article (PubMed ID: 6375329)
1. Disparate unloading efficacy of the calcium channel blockers, verapamil and nifedipine, on the failing hypertensive left ventricle.
Guazzi MD; Cipolla C; Della Bella P; Fabbiocchi F; Montorsi P; Sganzerla P
Am Heart J; 1984 Jul; 108(1):116-23. PubMed ID: 6375329
[TBL] [Abstract][Full Text] [Related]
2. Clinical use of calcium channel blockers as ventricular unloading agents.
Guazzi MD; Cipolla C; Sganzerla P; Agostoni PG; Fabbiocchi F; Pepi M
Eur Heart J; 1983 Jan; 4 Suppl A():181-7. PubMed ID: 6220895
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular unloading with calcium antagonists.
Guazzi MD
G Ital Cardiol; 1984 Sep; 14(9):694-8. PubMed ID: 6239802
[TBL] [Abstract][Full Text] [Related]
4. Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Miller AB; Conetta DA; Bass TA
Am J Cardiol; 1985 May; 55(11):1359-62. PubMed ID: 3993570
[TBL] [Abstract][Full Text] [Related]
5. Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema.
Polese A; Fiorentini C; Olivari MT; Guazzi MD
Am J Med; 1979 May; 66(5):825-30. PubMed ID: 443258
[TBL] [Abstract][Full Text] [Related]
6. Verapamil but not nifedipine impairs left ventricular function during exercise in hypertensive patients.
Ashmore RC; Corkadel LK; Green CL; Horwitz LD
Am Heart J; 1990 Mar; 119(3 Pt 1):636-41. PubMed ID: 2309606
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of calcium-channel blocking agents on left ventricular function during acute ischemia in dogs with and without congestive heart failure.
Urquhart J; Epstein SE; Patterson RE
Am J Cardiol; 1985 Jan; 55(3):10B-16B. PubMed ID: 3969856
[TBL] [Abstract][Full Text] [Related]
8. Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failure.
Lewis BS; Shefer A; Merdler A; Flugelman MY; Hardoff R; Halon DA
Am Heart J; 1988 Jun; 115(6):1238-44. PubMed ID: 3376841
[TBL] [Abstract][Full Text] [Related]
9. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
Packer M; Medina N; Yushak M
J Am Coll Cardiol; 1984 Nov; 4(5):890-901. PubMed ID: 6491082
[TBL] [Abstract][Full Text] [Related]
10. The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris.
Silke B; Verma SP; Nelson GI; Ahuja RC; Hussain M; Taylor SH
Br J Clin Pharmacol; 1984 Jun; 17(6):735-43. PubMed ID: 6743468
[TBL] [Abstract][Full Text] [Related]
11. Nifedipine in severely hypertensive patients with congestive heart failure and preserved ventricular systolic function.
Given BD; Lee TH; Stone PH; Dzau VJ
Arch Intern Med; 1985 Feb; 145(2):281-5. PubMed ID: 3156567
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension.
Young TE; Lundquist LJ; Chesler E; Weir EK
Am J Cardiol; 1983 Jan; 51(1):195-200. PubMed ID: 6571766
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension.
Diamond JA; Krakoff LR; Goldman A; Coplan N; Gharavi A; Martin K; Goldsmith R; Henzlova MJ; Machac J; Phillips RA
Am J Hypertens; 2001 Mar; 14(3):231-40. PubMed ID: 11281234
[TBL] [Abstract][Full Text] [Related]
14. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
Rosing DR; Idänpään-Heikkilä U; Maron BJ; Bonow RO; Epstein SE
Am J Cardiol; 1985 Jan; 55(3):185B-195B. PubMed ID: 3881913
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic and myocardial performance characteristics after verapamil use in congestive heart failure.
Ferlinz J; Citron PD
Am J Cardiol; 1983 May; 51(8):1339-45. PubMed ID: 6846161
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms.
Kaltenbach M; Hopf R
J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():59-68. PubMed ID: 4040978
[TBL] [Abstract][Full Text] [Related]
17. Use of calcium channel blockers in hypertrophic cardiomyopathy.
Lorell BH
Am J Med; 1985 Feb; 78(2B):43-54. PubMed ID: 4038850
[TBL] [Abstract][Full Text] [Related]
18. Calcium-channel blocking agents.
Leonard RG; Talbert RL
Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
[TBL] [Abstract][Full Text] [Related]
19. Calcium antagonists in heart failure.
Klugmann S; Salvi A; Camerini F
Herz; 1983 Apr; 8(2):88-92. PubMed ID: 6852766
[TBL] [Abstract][Full Text] [Related]
20. [Role of calcium antagonists in the pharmacologic treatment of heart insufficiency].
de Sá ME
Rev Port Cardiol; 1989; 8(7-8):547-52. PubMed ID: 2698718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
